Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Phase 4

Bilateral Erector Spinae Plane Block Versus Bilateral Quadratus Lumborum Plane Block for Postoperative Anaelgesia After Lumbar Spine Surgery

NCT07517822 · tracked via the Priya Life Science Egypt tracker
Phase
Phase 4
Started
2025-12-01
Last updated
2026-04-08

Condition(s) studied

Anaesthesia

Investigational drug(s) / intervention(s)

Ultrasound-guided quadratus lumborum block (QLB)

Ultrasound-guided quadratus lumborum block (QLB): And ultrasound guided QLB block with transmuscular approach was performed using 0.5 ml/kg 0.25% bupivacaine to the patients in QLB group

Study summary

The aim of this study is to compare postoperative analgesia and duration for each block performance plus complications after surgery in lumbar spine fixation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Aged between 18 and 65 years. * American Society of Anesthesiologists (ASA) physical status I to II. * Body mass index (BMI) less than 35 kg/m2. Exclusion Criteria: * Revision surgery. * More than three levels surgery. * Abnormal state of blood coagulation. * Chronic opioid consumption. * Local infection at the injection site). * Allergy to any involved medications. * Taking opioids within the past two weeks prior to surgery. * Time of surgery more than 4 hours.

Primary outcome measure(s)

  • Comparison between postoperative analgesia of QLB and ESPB after lumbar spine surgery via VAS score measurement — VAS Score will be used to assess pain or discomfort in postoperative at 2, 4, 6, 12, 24 hours
    The Visual Analog Scale (VAS) is used to assess pain intensity. It consists of a 10 cm line where 0 indicates "no pain" and 10 indicates "the worst possible pain." Higher scores indicate greater pain intensity.

Trial sites (1)

FacilityCityRegionStatus
AinShamsU Cairo Cairo Governorate
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07517822 on ClinicalTrials.gov ↗ ← All trials in Egypt